NCT04799847 2023-02-13
Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine
LintonPharm Co.,Ltd.
Phase 1/2 Unknown
Clinical Trials
6 trialsNCT05108077 2022-01-14
Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Phase 1/2 Unknown
NCT04922047 2021-06-11
TACBIN-01
RenJi Hospital
Phase 1/2 Unknown
NCT03560479 2020-08-19
A First-in-Human Study of alpha1H in Patients With Non-muscle Invasive Bladder Cancer
Hamlet Pharma AB
Phase 1/2 Unknown
NCT02886897 2016-09-01
A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors
Sun Yat-sen University
Phase 1/2 Unknown
NCT00818350 2009-01-07
Activity Study of Sunitinib In Metastatic Pretreated Urothelial Cancer
Campania Younger Oncologists Association
Phase 1/2 Unknown